Juvenile Idiopathic Arthritis (JIA)
Clinical Characteristics, Drugs, Assessment, and Disease Subtypes
DOI:
https://doi.org/10.5281/zenodo.15282922Abstract
Abstract Views: 161
Juvenile idiopathic arthritis (JIA) is a common type of arthritis in children and adolescents. This observational study was conducted in Baghdad (2019–2021). Records of JIA patients (n = 66) were documented from the teaching hospital in Al-Rusafa and Kadhimiya teaching hospital in Al-Karkh. JIA was categorised into 5 groups: Oligo JIA-Extended (OJIA-E) (n=16), OJIA-Persistence (OJIA-P) (n=15), Poly JIA (PJIA) (n=29), Systemic JIA (SJIA) (n=3), and Enthesitis-related Arthritis (ERA) (n=4). The Juvenile Arthritis Disease Activity Score-27 (JADAS 27) was used to measure disease activity for several months. JIA distribution in males and females (45.5% and 54.5%), respectively. The highest frequency of JIA type was observed in the age group 1-4 years with Oligo P (75%). Positive ANA test cases were found in 4 cases only. Four types of drugs and three types of biological drugs were found to be used to treat JIA. JADAS ranged from (8.1±5.7) to (19.4±8.6) with significant differences (p<0.05). Significant differences were noticed among the types of JIA in some blood tests and liver enzymes. The incidence of JIA decreased from 0.10/ 100000 to 0.005/ 100000. JIA with MTX, DMARDS duration, Steroid dosage, and JADAS all showed significant differences. There were no discernible differences in JIA with age, gender, disease duration, quantity of DMARDS, and blood tests.
Keywords:
ANA, DMARDS, Juvenile idiopathic arthritis, OligoarticularReferences
Martini, A., Lovell, D. J., Albani, S., Brunner, H. I., Hyrich, K. L., Thompson, S. D., & Ruperto, N. (2022). Juvenile idiopathic arthritis. Nature Reviews Disease Primers, 8(1), 5. https://doi.org/10.1038/s41572-021-00332-8
Tupper, S. (2012). Within-day variability of pain in youth with juvenile idiopathic arthritis and non-arthritic pain conditions (Doctoral dissertation, University of Saskatchewan).
Stinson, J., Connelly, M., Kamper, S. J., Herlin, T., & April, K. T. (2016). Models of care for addressing chronic musculoskeletal pain and health in children and adolescents. Best Practice & Research Clinical Rheumatology, 30(3), 468-482. https://doi.org/10.1016/j.berh.2016.08.005
Stinson, J. N., Luca, N. J., & Jibb, L. A. (2012). Assessment and management of pain in juvenile idiopathic arthritis. Pain Research and Management, 17(6), 391-396. https://doi.org/10.1155/2012/237258
Fadl, A. A., Alsuwaidani, S. A. H., Batti, S. M. A., Saleh, Z. H. S. A., Ghareeb, F. A. A., Alrebh, Z. H. A., Omran, L. A. A., ALRadhwan, M. S., Almarhoon, F. H. A., Almutlaq, Z. A. S. and Aysh, H. T. A. (2022) Overview on juvenile psoriatic arthritis: A Review, Journal of Pharmaceutical Research International, 34(61), pp. 1–7. https://doi.org/10.9734/jpri/2022/v34i617274
Zaripova, L. N., Midgley, A., Christmas, S. E., Beresford, M. W., Baildam, E. M., & Oldershaw, R. A. (2021). Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatric Rheumatology, 19, 1-14. https://doi.org/10.1186/s12969-021-00629-8
Rosenberg, A. M. (2020). Do we need a new classification of juvenile idiopathic arthritis? Clinical Immunology, 211. https://doi.org/10.1016/j.clim.2019.108298
Consolaro, A., Giancane, G., Schiappapietra, B., Davì, S., Calandra, S., Lanni, S., & Ravelli, A. (2016). Clinical outcome measures in juvenile idiopathic arthritis. In Pediatric Rheumatology (Vol. 14, Issue 1). BioMed Central Ltd. https://doi.org/10.1186/S12969-016-0085-5
Bazso, A., Consolaro, A., Ruperto, N., Pistorio, A., Viola, S., Magni-Manzoni, S., Malattia, C., Buoncompagni, A., Loy, A., Martini, A., & Ravelli, A. (2009). Development and testing of reduced joint counts in juvenile idiopathic arthritis. Journal of Rheumatology, 36(1), 183–190. https://doi.org/10.3899/jrheum.080432
Giancane, G., Rosina, S., Consolaro, A., & Ruperto, N. (1926). Outcome Scores in Pediatric Rheumatology. https://doi.org/10.1007/s11926-021-00988-x/Published
Standardization of Uveitis Nomenclature (SUN) Working Group. (2021). Classification criteria for juvenile idiopathic arthritis–associated chronic anterior uveitis. American Journal of Ophthalmology, 228, 192-197. https://doi.org/10.1016/j.ajo.2021.03.055
Consolaro, A., Giancane, G., Alongi, A., van Dijkhuizen, E. H. P., Aggarwal, A., Al-Mayouf, S. M., Bovis, F., De Inocencio, J., Demirkaya, E., Flato, B., Foell, D., Garay, S. M., Lazăr, C., Lovell, D. J., Montobbio, C., Miettunen, P., Mihaylova, D., Nielsen, S., Orban, I., … Wouters, C. (2019). Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. The Lancet Child and Adolescent Health, 3(4), 255–263. https://doi.org/10.1016/S2352-4642(19)30027-6
Abou El-Soud, A. M., El-Najjar, A. R., El-Shahawy, E. E., Amar, H. A., Hassan, T. H., Abd-Allaha, S. H., & Ragab, H. M. (2013). Prevalence of juvenile idiopathic arthritis in Sharkia Governorate, Egypt: Epidemiological study. Rheumatology International, 33(9), 2315–2322. https://doi.org/10.1007/s00296-013-2707-2
Kronzer, V. L., Bridges, S. L., & Davis, J. M. (2021). Why women have more autoimmune diseases than men: An evolutionary perspective. Evolutionary Applications, 14(3), 629–633. https://doi.org/10.1111/eva.13167
Tincani, A., Gerardi, M. C., Fredi, M., & Andreoli, L. (2018). Gender differences in rheumatology and the point of view of the Italian Society for Rheumatology (SIR). Journal of Sex-and Gender-Specific Medicine, 4(2), 79.
Al-Hemairi, M. H., Albokhari, S. M., & Muzaffer, M. A. (2016). The pattern of juvenile idiopathic arthritis in a single tertiary center in Saudi Arabia. International Journal of Inflammation, 2016. https://doi.org/10.1155/2016/7802957
Al-Mayouf, S. M., Al Mutairi, M., Bouayed, K., Habjoka, S., Hadef, D., Lotfy, H. M., Scott, C., Sharif, E. M., & Tahoun, N. (2021). Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East. In Pediatric Rheumatology (Vol. 19, Issue 1). BioMed Central Ltd. https://doi.org/10.1186/s12969-021-00650-x
Goebel, J. C., Roesel, M., Heinz, C., Michels, H., Ganser, G., & Heiligenhaus, A. (2011). Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. British Journal of Ophthalmology, 95(2), 209–213. https://doi.org/10.1136/bjo.2009.173542
Brunner, H. I., Ruperto, N., Zuber, Z., Keane, C., Harari, O., Kenwright, A., Lu, P., Cuttica, R., Keltsev, V., Xavier, R. M., Calvo, I., Nikishina, I., Rubio-Pérez, N., Alexeeva, E., Chasnyk, V., Horneff, G., Opoka-Winiarska, V., Quartier, P., Silva, C. A., … Schikler, K. (2015). Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, 74(6), 1110–1117. https://doi.org/10.1136/annrheumdis-2014-205351
Burns, P. B., Rohrich, R. J., & Chung, K. C. (2011). The levels of evidence and their role in evidence-based medicine. Plastic and Reconstructive Surgery, 128(1), 305–310. https://doi.org/10.1097/PRS.0b013e318219c171
Horneff, G., Klein, A., Ganser, G., Sailer-Höck, M., Günther, A., Foeldvari, I., & Weller-Heinemann, F. (2017). Protocols on classification, monitoring and therapy in children’s rheumatology (PRO-KIND): Results of the working group Polyarticular juvenile idiopathic arthritis. In Pediatric Rheumatology (Vol. 15, Issue 1). BioMed Central Ltd. https://doi.org/10.1186/s12969-017-0206-9
Berard, R. A., & Laxer, R. M. (2013). Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis. Expert Opinion on Biological Therapy, 13(11), 1623–1630. https://doi.org/10.1517/14712598.2013.840580
Al-Bassam, W. W., Ad’hiah, A. H., & Mayouf, K. Z. (2020). Biomarker significance of interleukin-18 in juvenile idiopathic arthritis. Iraqi Journal of Science, 61(12), 3200–3207. https://doi.org/10.24996/ijs.2020.61.12.7
Berthold, E., Månsson, B., & Kahn, R. (2019). Outcome in juvenile idiopathic arthritis: A population-based study from Sweden. Arthritis Research and Therapy, 21(1). https://doi.org/10.1186/s13075-019-1994-8
Laaksonen, A. L., Koskiahde, V., & Juva, K. (1974). Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus: a clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine. Scandinavian Journal of Rheumatology, 3(2), 103-108. https://doi.org/10.3109/03009747409115809
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Biomedicine and Chemical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
